Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) ...

John Crowley doesn’t worry about where his kids’ toys are made, but he told the Senate Health, Education, Labor and Pensions Committee that he does care where their medicines are made. His concerns, ...

The startup is using an AI-powered platform to help reduce the blue-collar labor shortage. Whats next for healthcare in ...

Automation will help the cell therapy sector reduce production costs, resulting in lower-priced products that increase patient accessibility.

Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...